Trial Profile
A multi-centre randomized placebo-controlled double blind study of Rituximab in patients with active PsA
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 26 May 2011 New trial record